Arkolith/Insider Trading/MREO/Form 4

Hughes-Wilson Alexandra

See RemarksMereo BioPharma Group plc (MREO) · full profile →Form 4 · filed Sep 16, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$637K
Net Open-Market Flow
-$637K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 13, 2024Sell(S)84K$4.22$355K50K
Sep 13, 2024Sell(S)16K$4.22$69K134K
Sep 12, 2024Sell(S)40K$4.47$179K151K
Sep 12, 2024Sell(S)8K$4.47$35K191K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-106968) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML